ReportsnReports - Warner-Chilcott Plc: PharmaVitae Report
11-Dec-2011 | News-Press Release
This analysis Warner-Chilcott Plc: PharmaVitae Report examines the historical and forecast performance for Warner-Chilcott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits
• Gain insight into Warner-Chilcott’s strategic outlook across the next 6 years.
• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source.
Browse All: Pharmaceuticals Market Research
Table Of Contents
ABOUT THIS REPORT
PharmaVitae Explorer database
Chapter structure
Strategic insight
Company introduction
Sales analysis
Financial analysis
Product analysis
Data sourcing
Analyst consensus
EXECUTIVE SUMMARY
Key findings
Warner Chilcott prescription pharma sales outlook
Warner Chilcott financial outlook
SWOT analysis
Weaknesses
Opportunities
Threats
STRATEGIC INSIGHT
Proctor & Gamble acquisition will shape performance through to 2016
Portfolio has undergone substantial change
Impact of expiries increased by narrower product focus
Patent expiries non-negotiable – pre-erosion cash flow critical to future expansion
P&G acquisition will drive superior operating performance…
and provide platform for further diversification and strategic evolution
COMPANY INTRODUCTION
Background
M&A history
SALES ANALYSIS
Key findings
Prescription pharmaceutical sales and growth rate analysis, 2004–16
Product analysis
Product analysis, 2010–16
Therapy area analysis
Geographic analysis
Launch/core/expiry analysis
Explanation of launch/core/expiry analysis
Launch analysis, 2010–16
Core analysis, 2010–16
Expiry analysis, 2010–16
Launch/core/expiry configuration, 2010–16
Molecule type analysis
Externalization analysis
FINANCIAL ANALYSIS
Key findings
Operating costs and profit analysis
Operating costs and profit analysis, 2004–10
Operating cost ratio and profit margin analysis, 2004–10
Operating cost ratio and profit margin analysis, 2010–16
Operating costs and profit analysis, 2010–16
PRODUCT ANALYSIS
Overview
Asacol
Actonel
Enablex
Loestrin
Estrace
Doryx
APPENDIX
References
Exchange rates
About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/
This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.
Author Info
Tag Cloud
- PharmaVitae ReportPharmaceuticals Market Research Reportsmarket researchindustry analysismarket share
Categories
More Releases
- Vitamins and Provitamins - Top 5 European Markets
- 2012 Deep Research Report on China Special Steel Industry
- ReportsnReports: Emerging Opportunities and Growth Prospects in the Mexican Travel Intermediaries Industry, Analyses and Forecasts to 2016
- ReportsnReports - The Future of Italian Foodservice Industry to 2016
- ReportsnReports: Germany – The Future of HNWIs to 2016: Wealth in the Powerhouse of Europe
- ReportsnReports: 2012 Deep Research Report on China PV Power Station Operator
- ReportsnReports: The Future of Retailing in Chile to 2016
- ReportsnReports: Global Markets for Media, Sera and Reagents in Biotechnology
- ReportsnReports: Amusement Park Foodservice Trends in the U.S.
- ReportsnReports - Battery Control Technology: Global Markets